Variablea |
Baseline (n=12) |
3 months – baseline (n=12) |
6 months – baseline (n=11) |
Summary |
Pe |
Summary |
Pe |
SGRQb |
|
|
|
|
|
Symptoms |
52.4 (41.9, 79.2) |
-22 (-26.3, -9.3) |
0.016 |
-6.5 (-27.6, -1.7) |
0.12 |
Activity |
62.8 (27.8, 70.8) |
0.0 (-16.7, 11.6) |
0.49 |
-0.9 (-19.6, 4.9) |
0.43 |
Impacts |
29.3 (20.7, 39.9) |
-2.5 (-4.8, 9.5) |
0.79 |
-4.2 (-14.0, 9.3) |
0.46 |
Total |
42.2 (29.2, 55.3) |
-5.1 (-10.9, 6.5) |
0.47 |
-7.4 (-16.2, 11.8) |
0.37 |
SF-12c |
|
|
|
|
|
Physical subscale |
38.3 (25.3, 50.3)d |
-1.7 (-7.6, 7.1) |
0.58 |
2.3 (-4.1, 7.3) |
0.63 |
Mental subscale |
51.1 (41.2, 56.1)d |
3.0 (-3.3, 10.8) |
0.24 |
3.0 (1.0, 7.6) |
0.049 |
aThe sample median (25th and 75th percentile) is given for numerical variables. bSt. George Respiratory Questionnaire (SGRQ) smaller index score indicates less chronic airflow limitations. cShort Form-12 (SF-12) scores have a mean of 50 and standard deviation of 10 in the general U.S. population; higher scores correspond to higher health levels. dSF-12 data was incomplete for one patient at baseline. eP-values refer to changes since baseline and result from Wilcoxon signed rank tests. |
|